Abdelrahman Hamdi

8PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical devicesCheminformatics and quantitative structure-activity relationshipsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 24, 2026
5-Arylidene-3-aryl-imidazol-4-ones as dual VEGFR-2/c-Met inhibitors: design, synthesis, and anticancer evaluation.

|Apr 24, 2026
Discovery of thieno[2,3-d]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and in vivo validation in a breast cancer model.

|Jul 11, 2025
Click Chemistry-Aided Synthesis of Triazole-Tethered Benzothiazoles as Novel Multifunctional Agents Against Alzheimer's Disease.

Mostafa M Elbadawi, Abdullah A Elgazar, Ahmed A Hefny

|Jun 27, 2025
Khellin Mitigates Cisplatin-Induced Renal Injury by Targeting Oxidative Stress, Inflammation, and Apoptosis: Integration of Network Pharmacology, Molecular Docking, and Preclinical Validation.

Zeina W Sharawi, Shimaa A Abass, Manal A Zubair

|Aug 21, 2024
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study.

Samar S Tawfik, Abdelrahman Hamdi, Ahmed R Ali

|Jul 13, 2024
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study.

Wafaa A Ewes, Samar S Tawfik, Aya M Almatary

Pageof 2

Frequent Collaborators

6 joint publications

Abdullah A Elgazar

3 joint publications

Mohammed A El-Magd

3 joint publications

Mashooq Ahmad Bhat

3 joint publications

Hamed W El-Shafey